Skip to main content
mudy4avm1qo9ozhyx65z30lwh26du8tg.png

mudy4avm1qo9ozhyx65z30lwh26du8tg.png
LIFESTENT® SOLO™ Vascular Stent System

Stents and Stent Grafts

Healthcare Professional Downloads:

Request Information Customer Service
1-800-321-4254

Features:

  • FDA-approved for the SFA and full popliteal artery
  • Longest lesion length indication (up to 240 mm)1
  • Proven performance in long lesions2
  • Designed for enhanced distal and proximal stent placement accuracy
  • Treat longer lesions with one stent
mudy4avm1qo9ozhyx65z30lwh26du8tg.png

mudy4avm1qo9ozhyx65z30lwh26du8tg.png

About LifeStent® Solo Vascular Stent

The LifeStent® Solo Vascular Stent is the first commercially available 200 mm stent in the U.S. and potentially enables a single-stent solution. The LifeStent® Solo Vascular Stent has sustained effectiveness up to three years in longer lesions. Furthermore, its enhanced delivery system is designed to reduce delivery system-dependent stent compression or elongation and enhance deployment accuracy. The LifeStent® Vascular Stent Systems, in varying sizes, have been studied in more than ten clinical trials in the United States and globally.

The LifeStent® Solo Vascular Stent is a peripheral stent intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 240mm in length in the native superficial femoral artery (SFA) and popliteal artery with reference vessel diameters ranging from 4.0 – 6.5mm. The LifeStent® Vascular Stent is the only FDA-approved stent for the SFA and full popliteal artery. The LifeStent® Solo Vascular Stent is available in 6 mm and 7 mm diameters and 200 mm in length.

Additionally, the LifeStent® Vascular Stent is available in 5 mm, 6 mm, and 7 mm diameters; and 20 mm to 170 mm in length. To learn more about the LifeStent® Vascular Stent, please click here

LIFESTENT® SOLO™ Image

LIFESTENT® SOLO™ Image

Specifications

Product Item IDProduct Item NameStent DiameterStent LengthCatheter LengthGuidewireCatheter DiameterUnits/Each
EX062002CLLIFESTENT® SOLO™ Vascular Stent, 6 mm x 200 mm, on a 100 cm, 6 French Catheter.6 mm200 mm100 cm0.035"6F1
EX062003CLLIFESTENT® SOLO™ Vascular Stent, 6 mm x 200 mm, on a 135 cm, 6 French Catheter.6 mm200 mm135 cm0.035"6F1
EX072002CLLIFESTENT® SOLO™ Vascular Stent, 7 mm x 200 mm, on a 100 cm, 6 French Catheter.7 mm200 mm100 cm0.035"6F1
EX072003CLLIFESTENT® SOLO™ Vascular Stent, 7 mm x 200 mm, on a 135 cm, 6 French Catheter.7 mm200 mm135 cm0.035"6F1

1 As of August 2016

2 LifeStent® Solo™ Vascular Stent Delivery System Study. A single-arm, prospective, non-randomized, multi-center study evaluating the safety and effectiveness of the LifeStent® Solo™ in the treatment of symptomatic vascular disease of the SFA and/or proximal popliteal artery. Subjects were treated with conventional PTA followed by implantation of the LifeStent® Vascular Stent. The LifeStent® 5 mm diameter was not included in this trial.

3 RESILIENT I Trial, RESILIENT II Trial, E-TAGIUSS Trial, Retrospective Analysis of LifeStent® Vascular Stent Systems in the Treatment of Long-Segment Lesions, LifeStent® Vascular Stent Delivery System Study (LifeStent® 200 mm Trial),REALITY I Trial,REALITY II Trial, ETAP Trial, CONTINUUM Trial, and RELIABLE Trial. Additional trials ongoing.

1